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Background 
This study explores the evidence-base for recommendations by the National Institute of Health and 
Care Excellence (NICE) Interventional Procedures Advisory Committee (IPAC); the only NICE 
committee not to consider cost. The four types of recommendation are: Standard Arrangements (can 
be done without restriction in the NHS); Special Arrangements (can be done under certain
conditions); Research Only; and Do Not Do. 
Methods 
Quantitative content analysis of data extracted from all published Interventional Procedure Guidance 
(IPG) for 2003-2018 (n=496). All data were extracted independently by two researchers, and 
disagreements clarified by consensus. Data were tabulated, descriptive statistics produced, and 
regression analyses performed. 
Results 
Proportion of IPGs by recommendation: 50% Standard; 37% Special; 11% Research Only; 2% Do 
Not Do. There was a clear trend over time: the proportion of Standard Arrangements 
recommendations has decreased, while the evidence threshold has increased. Adjusted mean numbers 
of patients in the evidence base by recommendation type: Standard=4867; Special=709; Research 
Only=386. Regression analyses confirm that the year of recommendation, numbers of patients, nd 
levels of evidence, all affect the likely recommendation. 
Conclusion 
This study demonstrates for the first time that the likelihood of achieving the most positive 
recommendation (Standard Arrangements) is decreasing, and that this is most likely due to evidential 
requirements becoming more demanding. These findings are distinct from those report d for other 
NICE committees, for which the cost and statistical superiority of new therapies are among the drivers 
of recommendations. This is an important finding regarding changing demands in the field of health 
policy. 
Introduction  
The National Institute of Health and Care Excellence (NICE) Interventional Procedures Advisory 
Committee (IPAC) is an independent advisory committee that has produced guidance for the National 
Health Service (NHS) in England and Wales since 2002. The objective of the Interventional 
Procedures (IP) programme is to appraise the efficacy and safety of interventional procedures, defined 
as those involving 'an incision, puncture, or entry into a body cavity, or the use of ionizing, 
electromagnetic, or acoustic energy'.1 A rapid review of published evidence is conducted by NICE 
and detailed summaries of the most relevant evidence and data are provided to th  committee, 
together with written commentaries elicited from clinical and surgical experts. Based on this evidence, 
the committee drafts recommendations for public consultation, after which they are reconsidered by 
the committee and revised if necessary. Interventional Procedures Guidance (IPG) is then ratified by 
NICE’s Guidance Executive and published.  
The committee can make four main types of recommendation: 1) ‘Standard’ (formally 'Normal') 
Arrangements indicate that the intervention can be performed in the NHS as routine practice. This is 
the most positive recommendation from the committee and requires a valid, relevant and good quality 
evidence-base of an appropriate size and consistency; 2) ‘Special Arrangements’ is more restrictive. 
This requires clinicians who use the procedure to inform the clinical governance lead in their trust, tell 
the patient about the uncertainties related to safety and efficacy of the procedure, and collect further 
data by means of audit or research. This recommendation is usually made if there are significant 
uncertainties in the evidence on efficacy or safety, or an inadequate quantity of evidenc ; 3) Research 
Only recommendations are made when there are substantial uncertainties related to the efficacy and 
safety of a procedure, which can only be resolved by further research; 4) Finally, the committee might 
recommend 'Do Not Do', if the evidence suggests that a procedure has no efficacy or poses 
unacceptable safety risks. It is important to note also that IPAC does not take account of cost(s) in any 
of its considerations. 
Previous research linked to this NICE committee has focused on the role and value of input from 
experts and other stakeholders, so-called ‘non-technical’ knowledge.2-5 This research had stressd the 
value of this input, but does not quantify its impact on recommendations. By contrast, the present 
study only focuses on so-called ‘technical’ evidence, i.e. the published data of studies included in the 
documents used by IPAC to make its decisions, and seeks to quantify its potential impact on 
recommendations. 
Similar research has been conducted on other NICE committees, especially those that consider cost. 
In studies of factors predicting decisions for Multiple and Single Technology Appraisals (MTAs, 
STAs) by NICE, analyses have consistently found that cost and clinical efficacy are among the drivers 
of committee recommendations.6-8 This is the first study to analyse recommendations from a NICE 
committee that does not consider cost. 
This paper therefore aims to assess on the relationship between the published evidence-bas  and the 
recommendations of IPAC. In doing so, it applies the principles of the Oxford Centre for Evidence-
Based Medicine’s evidence hierarchy with Level 1 (systematic review) and Level 2 (Randomised 
Controlled Trial [RCT]) being the highest levels 9, as this is consistent with much evidence-based 
practice and guidelines, and is in accordance with the basic categorisations outlied for primary 
research by the IDEAL framework for surgical innovation.10 
 
Methods  
This study used quantitative content analysis to produce a numerically-based summary of counts of 
key categories, and to analyse patterns of this content11,12 These categories are pre-specified and 
independent of the source(s) being analysed, e.g. study designs.13 The following data were extracted 
from the guidance and related evidence documents for each IPG published on the NICE website in 
August 2018: date; recommendation; total number of patients; number of patients in largest RCT (if 
there was an RCT); number of the following study designs: systematic reviews; RCTs; non-RCTs; 
cohort studies/case series; case reports; and registry data. A comments field faciltated data checking 
by recording any issues of interpretation. A single IPG was reported as multiple pieces of guidance if, 
for example, there were different recommendations for different populations. The majority of 
evidence summaries for IPGs from 2009 onwards reported the total numbers of patients, and umber 
and type of studies, within the evidence being considered by the committee. These data were 
extracted, where reported. Where these summary data were not reported, numbers of studies and 
patients were calculated by the authors from study details tabulated for consideration by the 
committee. The data extraction forms were piloted by all researchers on a sample of IPGs. 
Independent data extraction was performed for each IPG by two researchers (CC, RD, AB and RH), 
and all data cross-checked for discrepancies. Disagreements were resolved with reference to the 
original documents. The data were collated and tabulated, and descriptive statistics were present d.   
Statistical analysis 
Variables indicating evidence availability (i.e. systematic reviews, RCTs, registri s etc.) were 
dichotomised into ‘present’ or ‘not present’, and total numbers of patients in the included studies were 
grouped into five categories to minimise the impact of outliers on the logit models: <100, 100-999, 
1000-4999, 5000-9999, and >10000). Logistic regression analyses were performed to assess 
relationships between evidence availability variables with each level of recommendation versus all 
others (Do Not Do was excluded as there were only eight such recommendations). Ordered logit 
models were then used to further investigate how the availability of particul evidence may predict 
the level of recommendation achieved. These analyses assume a hierarchy in the IPAC 
recommendations, i.e. Standard Arrangements, Special Arrangements and Research only, ranked from 
best to worst. The assumption of proportional odds across response categories was t ted using a 
likelihood ratio test. Multiple logistic regression models were also run for individually significant 
predictor variables. All statistical analyses were performed in Stata 15.   
 
Results  
The search of the NICE website identified 496 separate pieces of guidance and/or recommendations 
published from 2003 to 2018. Each recommendation is routinely reviewed every three years if 
‘Standard’ Arrangements have not been given, thus cancelling the previous IPG and generating IPGs 
with designated numbers higher than 496 (e.g. IPG597). The basic results are presented in Table 1.  
The following proportions of each type of recommendation were: 50% Standard Arrangeme ts 
(248/496); 37% Special Arrangements (185/496); 11% Research Only (55/496); and 2% Do Not Do 
(8/496). If the highest level of available evidence was a systematic review, th n a Standard 
Arrangements recommendation was most likely; if it was only cohort studies/cas  series, then a 
Research Only recommendation was more likely (see Table 1). Where the evidence-base included an 
RCT, these trials tended to be larger for Standard Arrangements recommendations (62% of trials had 
>100 participants) than for Special Arrangements (42%) or Research Only (38%). 
 
<insert Table 1 here> 
 
The mean number of patients included in the evidence-base considered by the committee was also 
much higher for procedures that received the most positive recommendation and decrease  as the 
uncertainty around the intervention’s efficacy and safety increased, thus receiving the more restrictive 
recommendations: 7981 (Standard Arrangements); 3937 (Special Arrangements); 2479 (Research 
Only); 2012 (Do Not Do). When outliers in patient numbers that might skew the data were excluded 
(i.e. the three highest totals for the three recommendation-types with these clear outliers), then not 
only does the relative difference between the mean number of patients for each type of 
recommendation remain, but it also increases: Standard: 4867; Special: 709; Research Only: 386. 
There were also clear trends over time. The proportion and numbers of Standard Arrangements 
recommendations have reduced substantially over time, while numbers of Research Only 
recommendations have increased (to the point where there are now more of the latter than he former) 
(see Figure 1). 
 
<insert Figure 1 here> 
 
From 2007/2008 (see Figure 2), the proportion of Standard arrangements recommendations with a 
supporting systematic review has increased, while the proportion with case series/cohort/case-
control/case reports, and even RCTs, as the highest level of evidence has decre ed. The evidential 
requirements for Standard Arrangements are becoming more demanding (in the sample fro  2017 
and 2018, n=18, none had designs other than a systematic review or RCT as the ‘best available’ 
evidence). This same trend was found for the recommendation Special Arrangements (data not 
presented). The proportion of systematic reviews included as the highest level of evidence in a y IPG 
recommendation also increased over the period, from 23% in 2003-2010 to 33% in 2011-2018.  
 
<insert Figure 2 here> 
 
The descriptive findings presented in Table 1, and Figures 1 and 2 above, were confirmed by 
statistical analysis. The results of some of these analyses are presented in Tables 2 nd 3. Logistic 
regression analyses found that the probability of Standard Arrangements (compared to other ypes of 
recommendation, excluding Do Not Do) is significantly higher (2.55 times higher, p<0.001) if there is 
a relevant, available systematic review (see Table 2).  
 
<insert Table 2 here> 
 
The most important individual predictor of Standard Arrangements was the number of patients 
included in the evidence-base. The odds of a Standard Arrangements recommendation increased by 
10.57 times when 1000-4999 patients were included in the published evidence considered by th  
committee. It should be noted that the mean number of patients for Standard Arrangements, minus 
outliers, falls within this range (4867). The probability of a Standard Arrangements r commendation 
was also found to have decreased significantly between 2003 and 2018 (p<0.001), while the 
probability of a Research Only recommendation has increased significantly: Odds Ratio (OR) 1.17, 
95% Confidence Interval (CI), 1.09-1.25, p<0.001 (full data not presented). 
Finally, in multiple regression analysis of the statistically significant variables presented in Table 2, 
the following variables were found to be significant independent predictors (at the level of p<0.001) 
of a Standard Arrangements recommendation: year of decision, non-RCT, and categorised total 
patients (data not presented). The highest-level of evidence, a systematic review, was no longer a 
statistically significant independent predictor: OR, 1.64, 95% CI, 0.95-2.81, p=0.074. 
Ordered logit models were then used to investigate further how the availability of particular evidence 
might predict the level of recommendation achieved. The results are presented in Table 3 and confirm 
the findings of the regression analyses. An interventional procedure with a systematic review was 
2.45 times (p<0.001) more likely to receive a higher level of recommendation than one without, and 
categories of patients with the highest numbers were more likely to achieve a higher recommendation 
level than categories with lower numbers (OR 2.19, 95% CI 1.74-2.76, p<0.001).  
 
<insert Table 3> 
 
Significant predictors of a lower level of recommendation were year of guidance (with the odds of 
more positive recommendations decreasing by 0.11 each year) and the inclusion of case series and 
case reports (OR 0.43; p<0.001). Again, in multiple regression analyses of the statistically significant 
variables presented in Table 3, the same variables as in the regression were found to be statistically 
significant (p<0.01), but in this model systematic review also achieved statistical significance as an 
independent predictor (OR 1.89, 95% CI 1.52-3.32, p=0.014) (full data not presented). 
 
To illustrate these findings further, a typical example of each recommendation and its most common 
evidence-base (Level 1 for Standard Arrangements, Level 2 or 3 for Special etc.) is provided in the 
top half of Table 4. In each case, it is clear how the level and size of the evidence-base might have 
contributed to the recommendation decision.  
 
<insert Table 4> 
 
However, the bottom half of this table also provides an atypical example of each type of 
recommendation. These latter examples serve to highlight the fact that factors othe  than the level of 
evidence available or numbers of patients can also play a key role.  
In the case of the Standard Arrangements recommendation in IPG554 (see Table 4), the level of 
evidence was relatively low, as was the number of included patients (n=226), but the guidance 
stressed that, despite there being the ‘potential for some serious but well-recognised safety concerns’, 
there was some evidence of efficacy and few or no alternative interventions for those who were 
unsuitable for other types of surgery (i.e. there was unmet need). Tellingly, the same IPG 
recommended Special arrangements for patients for whom another type of surgery was an option.  
IPG429 represents an example of a Research Only recommendation that appears to satisfy he ‘level 
of evidence’ requirements for a Standard Arrangements recommendation. However, the procedure 
had clear safety risks; there were uncertainties over efficacy, and the data were considered 
insufficiently long-term. These issues, and optimal patient selection, could only be addressed by 
further research. A similar set of circumstances appears to apply in the case of IPG592 (Special 
Arrangements), where the evidence-base included a systematic review and covered more than 1000 
patients. However, as with IPG429, there were some uncertainties over efficacy (inconsistencies in 
findings across studies), but in this case there were no safety concerns. The recommendation was 
therefore Special Arrangements. 
These latter cases underline how an ostensibly ‘negative’ recommendation can be made confidently 
because of the availability of high-level evidence and large numbers of patients, as well as explaining 
how the highest levels of evidence can also produce the ‘weakest’ recommendations. This is also 
reflected in the eight recommendations for ‘Do Not Do’ (data not presented).  
 
Discussion  
The key findings of this study are that, as a proportion, fewer procedures are now achieving a 
Standard Arrangements recommendation, and an increasingly larger proportion of those that do have 
the highest level of evidence (systematic review). Therefore, the likelihood of the most positive 
recommendation has decreased over time, while the evidential requirements have increased, both in 
terms of the level and size of the evidence-base, i.e. patient numbers. Th  data and analyses do not 
demonstrate causality, but there is a clear correlation between these variables. Oth r NICE 
committees have also been less likely to give  full, positive recommendatio s in more recent years, 
but previous research has not demonstrated why there might be fewer wholly positive 
recommendations than previously.6 In the case of IPAC, the data strongly suggests that the 
committee’s decision-making is linked to ever-growing evidence requirements. Part of the reason for 
this demand might be because more and more systematic reviews are now being published and are 
available14, hence the increase in this level of evidence across all recommendations over this p riod 
(see Figure 2). 
However, as demonstrated by the case studies, IPAC’s decisions clearly involve a great deal more 
than simply deferring to any perceived ‘evidence hierarchy’. Committee recommendations cannot be 
reduced to simple algorithms based on study design or patient numbers. Even procedures with large 
numbers of patients in the published evidence have no guarantee of the most positive 
recommendation, as indicated by the mean and ranges presented in Table 1. Other factors cle rly also 
contribute to decision-making and recommendations. These might include: clinical/pat ent need 5; 
clinical input 2,3; the promise and plausibility of the procedure having real world impact 3; and, 
especially, the committee’s consideration of the studies and their results (particularly their 
homogeneity and consistency) in a patient and health system context. These factors apply to all NICE 
committees and act as a caution against seeking to predict all recommendations using the type and 
size of the evidence base alone, despite the strong evidence of this analysis.   
 
Strengths and limitations 
This paper is the first analysis of the predictors of recommendations by IPAC. t involved the double-
extraction and checking of data from almost 500 pieces of guidance from publicly-available 
documents produced by this committee from 2003-2018. However, the analyses were limited to those
data where potential impact on recommendations might be evaluated. As a result, they did not take 
into account other potentially important variables that are more difficult to quantify. These might 
include the role of expert or patient input in any specific recommendation; and the consistency and 
relative balance of the efficacy and safety evidence for a specific population and procedure; the 
presence of ‘unmet need’; and the degree to which the procedure being evaluated was novel or 
established. A relative lack of evidence – and thus the reduced likelihood of the most positive 
recommendations – might indicate that a procedure is new. However, it was not reasonably possible 
to discriminate, using the published data, between new and established procedures. Consequently, this 
factor has also not been analysed. The type of procedure being assessed might also be an independent 
predictor of the likely recommendation, but the IPGs do not specify type of procedure or surgical 
speciality, and categorisation using the British Medical Association’s Surgical Specialities list15 
proved problematic. As a result, the potential for recommendations to be predicted by ype of 
procedure is unknown. The very small number of Do Not Do recommendations (n=8) also prevented 
their analysis alongside the large numbers of other recommendations. Nevertheless, as demonstrated 
by the case studies presented in this paper, more in-depth analysis of individual pieces of guidance 
might present a rather richer picture of the process. 
 
This study has demonstrated for the first time that the level of the available evidence, and the number 
of patients included in that evidence-base, both strongly predict the likely IPAC recommendation. It 
also found that the burden of these evidential requirements has increased over time: the ost positive 
recommendation, Standard Arrangements, now more than ever requires the highest levels of evidence 
and/or large numbers of patients reported to have undergone a procedure in published studies. The 
likelihood of achieving the most positive recommendation is therefore decreasing as evidential 
requirements become more demanding. This is an important finding regarding changing demands in 
the field of health policy. However, the case studies presented here also demonstrate that decision-
making cannot be reduced to simple algorithms based on study design or patient numbers; factors 
other than the type and size of the evidence-base can also clearly contribute to the type of 
recommendation awarded. 
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Table 1: Interventional Procedures Guidance (IPG) 2003-2018: Evidence base characteristics  




































































Total 496 70 75 126 87 138 99   
N: Number, SR: Systematic review, RCT: Randomised controlled trial *The denominator in this column could be different 
from the total number of recommendations with RCTs because numbers of patients were not reported or could not be 




Table 2: Logistic regression analyses of Standard Arrangements vs other types of recommendation 
(excluding Do Not Do) 
Variable Odds ratio 95% CI 
Systematic review (y/n) 2.55 1.69 3.86 
Year of decision 0.90 0.87 0.94 
RCT (y/n) 1.48 1.02 2.13 
Categorised total pts (<100, 100-999, 1000-4999, 
5000-9999, >10000) 
2.35 1.83 3.01 
ORs by category 
100-1000 4.11 2.00 8.46 
1000-4999 10.57 4.88 22.92 
5000-9999 19.13 5.24 69.80 
>10000 18.36 5.53 60.99 
Non-RCT (y/n) 2.07 1.44 2.98 
Case/cohort series (y/n) 0.45* 0.20 1.02 
Registries (y/n) 0.61† 0.27 1.38 
CI: Confidence Interval, y/n: yes/no, RCT: Randomised Controlled Trial, p values ll <0.0001 unless stated. 
*p=0.055 †p=0.235 
 
Table 3: Ordered logit model odds of recommendations (excluding Do Not Do) 
Variable Odds ratio 95% CI 
Systematic review (y/n) 2.45 1.63 3.67 
Year of decision 0.89 0.86 0.93 
Categorised total pts 2.19 1.74 2.76 
ORs by category 
100-1000 2.56 1.53 4.30 
1000-4999 6.87 3.78 12.49 
5000-9999 11.97 3.61 39.75 
>10000 10.34 3.42 31.31 
RCT (y/n) 1.40* 0.99 2.00 
Non-RCT (y/n) 2.03 1.43 2.87 
Case/cohort series (y/n) 0.43 0.20 0.97 
Registries (y/n) 0.54† 0.26 1.15 
CI: Confidence Interval, y/n: yes/no, RCT: Randomised Controlled Trial, p values ll <0.0001 unless stated. 
*p=0.060, †p=0.114.  
 
Table 4: Illustrative examples of recommendations and their evidence-base  












Special 430 Partial replacement of the meniscus 
of the knee using a biodegradable 
scaffold 
RCT 600 
Research Only 519 Insertion of an epiretinal prosthesis 
for retinitis pigmentosa 




Standard 554 Balloon pulmonary angioplasty for 
chronic thromboembolic pulmonary 
hypertension 
non-RCT 226 
Special 592 High-intensity focused ultrasound 





Research Only 429 Endovascular stent insertion for 




IPG: Interventional Procedures Guidance, RCT: Randomised Controlled Trial 
 
 
 
 
 
 
 
